Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
247.6 EUR | +0.81% | -.--% | -.--% |
07/06 | Roche: efficacy of Evrysdi in spinal muscular atrophy | CF |
07/06 | Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ROCHE HOLDING AG | Other Pharmaceuticals | +0.81% | -.--% | -.--% | -.--% | +3.00% | 22TCr | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- ROG Stock
- RHO Stock
- Charts Roche Holding AG
- Comparison Chart